Complete Filing Data
Traws Pharma, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $28.31 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Traws Pharma, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$166.5M | -$18.9M | -$19.0M | -$16.2M | -$25.2M | -$21.5M | -$20.6M | -$24.1M | -$19.7M | -$24.0M | -$63.7M | -$62.5M | -$29.9M | -$26.3M |
| Revenue * | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2.2M | $1.2M | $787.0K | $5.5M | $11.5M | $800.0K | $4.8M | $46.2M | $1.5M |
| Operating Income Loss | -$142.4M | -$20.3M | -$19.6M | -$16.5M | -$25.0M | -$21.7M | -$23.3M | -$25.7M | -$23.7M | -$24.0M | -$63.7M | -$62.2M | -$22.3M | -$27.6M |
| General And Administrative Expense | $12.3M | $9.1M | $8.4M | $9.4M | $8.3M | $8.3M | $7.6M | $7.4M | $9.2M | $9.5M | $15.1M | $16.8M | $15.7M | $6.4M |
| Other Nonoperating Income Expense | $289.0K | $1.4M | $663.0K | $12.0K | $48.0K | $143.0K | $1.2M | $30.0K | $62.0K | -$35.0K | -$52.0K | $63.0K | $608.0K | $11.0K |
| Operating Expenses | $142.6M | $20.5M | $19.9M | $16.7M | $25.2M | $23.9M | $24.5M | $26.5M | $29.2M | $35.4M | $64.5M | $67.0M | $68.5M | $29.1M |
| Research And Development Expense | $11.4M | $11.4M | $7.3M | $16.9M | $15.5M | $16.9M | $19.1M | $20.1M | $25.9M | $49.4M | $50.2M | $52.8M | $22.6M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$18.9M | -$19.0M | -$16.2M | -$25.1M | -$21.5M | -$20.4M | -$24.1M | -$19.7M | -$24.0M | -$63.8M | -$62.5M | -$29.9M | -$26.3M | |
| Other Comprehensive Income Loss Net Of Tax | -$19.0K | $10.0K | -$19.0K | -$28.0K | $32.0K | -$6.0K | -$15.0K | $34.0K | -$9.0K | -$9.0K | -$14.0K | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$19.0K | $10.0K | -$19.0K | -$28.0K | $32.0K | -$6.0K | -$15.0K | $34.0K | -$9.0K | -$9.0K | -$14.0K | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$19.0K | $10.0K | -$19.0K | -$28.0K | $32.0K | -$6.0K | -$15.0K | $34.0K | -$9.0K | -$9.0K | -$14.0K | $1.0K | ||
| Comprehensive Income Net Of Tax | -$166.5M | -$18.9M | -$21.5M | -$20.6M | -$24.1M | -$19.7M | -$24.0M | -$63.7M | -$62.6M | -$29.9M | -$26.3M | |||
| Net Income Loss Available To Common Stockholders Basic | -$54.7M | -$18.9M | -$63.7M | -$64.9M | -$33.9M | -$30.3M | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$25.2M | -$21.5M | -$20.5M | -$24.1M | -$19.7M | -$24.0M | -$63.8M | -$62.1M | -$29.9M | -$26.3M | ||||
| Net Income Loss Attributable To Noncontrolling Interest | $163.0K | -$44.0K | -$113.0K | -$13.0K | ||||||||||
| Deferred Revenue Noncurrent | $4.1M | $4.5M | $5.0M | $13.5M | $13.9M | $15.4M | ||||||||
| Deferred Revenue Current | $455.0K | $455.0K | $455.0K | $455.0K | $788.0K | $3.9M | ||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $163.0K | -$44.0K | -$113.0K | -$13.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.0M | -$915.0K | $21.5M | -$8.5M | -$123.1M | -$5.0M | -$4.7M | -$4.3M | -$5.8M | -$5.4M | -$4.0M | -$4.1M | -$3.5M | -$4.2M | -$4.7M | -$6.2M | -$7.4M | -$5.1M | -$4.6M | -$3.6M | -$7.6M | -$5.3M | -$4.5M | -$5.1M | -$7.0M | -$2.6M | -$8.3M | -$1.6M | -$5.4M | -$7.2M | -$5.9M | -$9.0M | -$12.3M | -$13.4M | -$14.9M | -$16.8M | -$18.7M | -$14.6M | -$20.5M | -$12.6M | -$14.8M | -$10.3M | -$1.4M | -$7.4M | -$10.8M |
| Revenue * | $2.7M | $57.0K | $57.0K | $57.0K | $56.0K | $57.0K | $57.0K | $56.0K | $57.0K | $57.0K | $56.0K | $57.0K | $57.0K | $56.0K | $66.0K | $56.0K | $52.0K | $63.0K | $2.0M | $68.0K | $120.0K | $485.0K | $564.0K | $110.0K | $324.0K | $210.0K | $1.7M | $2.2M | $1.5M | $1.6M | $123.0K | $114.0K | $114.0K | $114.0K | $125.0K | $447.0K | $1.9M | $1.1M | $591.0K | $1.1M | $3.0M | $42.8M | $220.0K | $198.0K | |
| Operating Income Loss | -$4.1M | -$1.2M | -$5.2M | -$8.5M | -$123.3M | -$5.2M | -$5.1M | -$4.6M | -$6.1M | -$5.6M | -$4.1M | -$4.1M | -$4.0M | -$4.6M | -$4.1M | -$6.3M | -$7.3M | -$5.1M | -$5.1M | -$3.6M | -$7.2M | -$5.6M | -$5.6M | -$5.9M | -$6.8M | -$6.1M | -$6.8M | -$4.3M | -$5.4M | -$7.5M | -$5.9M | -$9.0M | -$12.3M | -$13.4M | -$14.9M | -$16.8M | -$18.7M | -$14.6M | -$20.1M | -$12.6M | -$15.0M | -$10.3M | $6.9M | -$8.2M | -$10.7M |
| General And Administrative Expense | $1.7M | $1.7M | $2.8M | $3.5M | $2.0M | $3.4M | $2.7M | $2.2M | $2.1M | $2.1M | $2.1M | $2.2M | $2.3M | $2.9M | $2.2M | $2.1M | $2.6M | $1.8M | $1.6M | $1.8M | $3.2M | $1.7M | $2.1M | $1.9M | $1.7M | $1.8M | $2.1M | $2.0M | $2.1M | $3.2M | $2.2M | $2.6M | $3.0M | $3.1M | $3.1M | $4.0M | $4.9M | $4.4M | $5.9M | $3.1M | $3.3M | $2.7M | $8.9M | $1.6M | $2.5M |
| Other Nonoperating Income Expense | $96.0K | $188.0K | $180.0K | $61.0K | $205.0K | $229.0K | $350.0K | $360.0K | $362.0K | $243.0K | $96.0K | $10.0K | $7.0K | -$13.0K | $19.0K | -$23.0K | $96.0K | $27.0K | $40.0K | $68.0K | $117.0K | $112.0K | $8.0K | $11.0K | $10.0K | $10.0K | $9.0K | $4.0K | -$18.0K | -$18.0K | -$14.0K | -$20.0K | -$19.0K | $1.0K | -$126.0K | $47.0K | $15.0K | $127.0K | $41.0K | $28.0K | -$2.0K | $541.0K | |||
| Operating Expenses | $4.1M | $4.0M | $5.3M | $8.6M | $123.4M | $5.3M | $5.1M | $4.7M | $6.2M | $5.7M | $4.2M | $4.2M | $4.0M | $4.7M | $4.2M | $6.3M | $7.4M | $5.2M | $5.2M | $5.7M | $7.3M | $5.7M | $6.1M | $6.5M | $6.9M | $6.4M | $7.0M | $6.0M | $7.6M | $9.0M | $7.5M | $9.1M | $12.5M | $13.5M | $15.0M | $16.9M | $19.2M | $16.5M | $21.2M | $13.2M | $16.1M | $13.3M | $35.9M | $8.4M | $10.9M |
| Research And Development Expense | $1.9M | $2.5M | $2.5M | $4.1M | $3.6M | $2.0M | $2.0M | $1.8M | $1.9M | $1.9M | $4.2M | $4.8M | $3.4M | $3.5M | $3.9M | $4.1M | $4.0M | $4.1M | $4.6M | $5.1M | $4.6M | $4.9M | $4.0M | $5.6M | $5.8M | $5.3M | $6.5M | $9.5M | $10.4M | $11.9M | $12.9M | $14.2M | $12.1M | $15.3M | $10.0M | $12.8M | $10.6M | $27.0M | $6.8M | $8.4M | |||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$5.0M | -$4.7M | -$4.3M | -$5.8M | -$5.4M | -$4.0M | -$4.1M | -$3.5M | -$4.2M | -$4.7M | -$6.2M | -$7.4M | -$5.1M | -$4.6M | -$3.6M | -$7.6M | -$5.4M | -$4.3M | -$5.1M | -$7.0M | -$2.6M | -$8.3M | -$1.6M | -$5.4M | -$7.2M | -$5.9M | -$8.9M | -$12.4M | -$14.9M | -$16.8M | -$18.7M | -$20.5M | -$12.6M | -$14.8M | |||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$3.0K | $28.0K | $23.0K | -$3.0K | -$7.0K | -$2.0K | -$1.0K | $6.0K | -$20.0K | -$20.0K | -$7.0K | -$8.0K | $4.0K | -$16.0K | $15.0K | $7.0K | -$6.0K | -$13.0K | $4.0K | -$6.0K | -$2.0K | -$16.0K | $8.0K | $9.0K | $16.0K | $5.0K | $2.0K | -$3.0K | $6.0K | -$4.0K | $29.0K | -$30.0K | -$8.0K | ||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$3.0K | $28.0K | $23.0K | -$3.0K | -$7.0K | -$2.0K | -$1.0K | $6.0K | -$20.0K | -$20.0K | -$7.0K | -$8.0K | $4.0K | -$16.0K | $15.0K | $7.0K | -$6.0K | -$13.0K | $4.0K | -$6.0K | -$2.0K | -$16.0K | $8.0K | $9.0K | $16.0K | $5.0K | $2.0K | -$3.0K | $6.0K | -$4.0K | $29.0K | -$30.0K | -$8.0K | ||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$3.0K | $28.0K | $23.0K | -$3.0K | -$7.0K | -$2.0K | -$1.0K | $6.0K | -$20.0K | -$20.0K | -$7.0K | -$8.0K | $4.0K | -$16.0K | $15.0K | $7.0K | -$6.0K | -$13.0K | $4.0K | -$6.0K | -$2.0K | -$16.0K | $8.0K | $5.0K | $6.0K | $29.0K | -$30.0K | -$8.0K | -$1.0K | -$23.0K | -$2.0K | $7.0K | |||||||||||||
| Comprehensive Income Net Of Tax | -$4.0M | -$887.0K | $21.5M | -$8.5M | -$123.1M | -$5.0M | -$4.7M | -$4.3M | -$4.6M | -$3.6M | -$7.6M | -$5.4M | -$4.5M | -$5.1M | -$7.0M | -$2.6M | -$8.3M | -$1.6M | -$5.4M | -$7.2M | -$5.9M | -$8.9M | -$12.4M | -$14.9M | -$16.8M | -$18.7M | -$20.5M | -$12.6M | -$14.8M | -$1.4M | -$7.4M | ||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$3.0M | -$625.0K | $15.1M | -$1.4M | -$20.8M | -$5.0M | -$13.4M | -$14.9M | -$16.8M | -$18.7M | -$14.6M | -$20.8M | -$13.6M | -$15.9M | -$11.3M | -$2.2M | -$8.3M | -$12.0M | |||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$13.4M | -$14.9M | -$16.8M | -$18.7M | -$14.6M | -$20.1M | -$12.6M | -$14.8M | -$10.3M | -$1.4M | -$7.4M | -$10.8M | |||||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$163.0K | -$20.0K | -$24.0K | -$20.0K | -$29.0K | -$27.0K | -$37.0K | -$13.0K | |||||||||||||||||||||||||||||||||||||
| Deferred Revenue Noncurrent | $4.2M | $4.3M | $4.4M | $4.7M | $4.8M | $4.9M | $13.1M | $13.2M | $13.3M | $13.6M | $13.7M | $13.8M | $14.0M | $14.1M | |||||||||||||||||||||||||||||||
| Deferred Revenue Current | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $455.0K | $2.5M | $3.5M | |||||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $163.0K | -$20.0K | -$24.0K | -$29.0K | -$27.0K | -$37.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $28.3M | $46.1M | $6.2M | $11.6M | $5.4M | -$11.7M | $4.3M | $10.0M | $22.7M | $80.4M | -$158.3M | -$138.4M | -$108.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $38.8M | $55.1M | $19.0M | $22.7M | $17.0M | $4.0M | $21.5M | $19.8M | |||||||
| Retained Earnings Accumulated Deficit | -$482.6M | -$463.7M | -$444.7M | -$428.6M | -$403.4M | -$381.9M | -$362.3M | -$338.2M | -$318.6M | -$294.6M | -$230.9M | -$168.4M | |||
| Property Plant And Equipment Net | $22.0K | $24.0K | $38.0K | $52.0K | $50.0K | $9.0K | $64.0K | $152.0K | $248.0K | $420.0K | $626.0K | $463.0K | |||
| Prepaid Expense And Other Assets Current | $1.8M | $561.0K | $332.0K | $722.0K | $650.0K | $760.0K | $820.0K | $1.6M | $1.8M | $3.1M | $4.4M | $1.7M | |||
| Other Assets Noncurrent | $1.0K | $1.0K | $10.0K | $150.0K | $150.0K | $149.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | |||
| Liabilities Current | $9.2M | $8.0M | $6.1M | $10.0M | $8.3M | $8.4M | $10.0M | $10.2M | $7.6M | $10.3M | $10.3M | $25.4M | |||
| Liabilities And Stockholders Equity | $22.7M | $39.4M | $55.5M | $20.0M | $23.7M | $17.9M | $5.0M | $23.2M | $23.4M | $47.3M | $105.2M | $83.9M | |||
| Liabilities | $12.0M | $11.1M | $9.4M | $13.8M | $12.1M | $12.5M | $15.8M | $18.1M | $12.6M | $23.7M | $24.3M | $40.8M | |||
| Common Stock Value | $9.0K | $209.0K | $209.0K | $124.0K | $1.1M | $57.0K | $8.0K | $68.0K | $25.0K | $217.0K | $215.0K | $26.0K | |||
| Assets Current | $22.7M | $39.3M | $55.4M | $19.8M | $23.5M | $17.8M | $4.9M | $23.1M | $23.2M | $46.9M | $104.4M | $83.3M | |||
| Assets | $22.7M | $39.4M | $55.5M | $20.0M | $23.7M | $17.9M | $5.0M | $23.2M | $23.4M | $47.3M | $105.2M | $83.9M | |||
| Additional Paid In Capital Common Stock | $493.3M | $491.8M | $490.6M | $434.6M | $413.9M | $387.2M | $350.6M | $342.5M | $328.6M | $317.1M | $311.1M | $10.0M | |||
| Accounts Payable Current | $5.6M | $3.9M | $2.8M | $4.8M | $4.3M | $4.0M | $6.2M | $5.3M | $3.4M | $4.0M | $3.7M | $5.5M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$23.0K | -$33.0K | -$14.0K | $14.0K | -$18.0K | -$12.0K | $3.0K | -$31.0K | -$22.0K | -$13.0K | $1.0K | ||||
| Receivables Net Current | $18.0K | $29.0K | $28.0K | $37.0K | $98.0K | $35.0K | $59.0K | $31.0K | $1.5M | $132.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $43.6M | $60.0M | $81.5M | $2.7M | $7.3M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $517.0K | -$17.9M | -$16.3M | $36.0M | -$3.7M | $5.8M | $12.9M | -$17.4M | |||||||
| Contract With Customer Liability Noncurrent | $2.8M | $3.0M | $3.2M | $3.5M | $3.7M | $3.9M | $4.1M | ||||||||
| Contract With Customer Liability Current | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $455.0K | ||||||||
| Accrued Liabilities Current | $3.4M | $4.0M | $3.1M | $5.0M | $3.8M | $4.2M | |||||||||
| Accrued Expenses And Other Current Liabilities Current | $3.3M | $4.4M | $3.7M | $5.8M | $5.8M | $3.9M | |||||||||
| Minority Interest | $830.0K | $830.0K | $830.0K | $874.0K | $487.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q4 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.5M | $8.3M | $6.0M | -$31.6M | -$2.0M | -$105.5M | $6.0M | $10.7M | $14.5M | $18.9M | $22.9M | $33.4M | $38.5M | $42.3M | $49.7M | $33.0M | $37.2M | $12.2M | $15.6M | $21.3M | -$6.0M | -$4.5M | -$1.5M | $10.9M | $15.9M | -$7.7M | -$6.9M | -$388.0K | -$3.5M | $9.2M | $1.2M | $6.0M | $3.4M | $3.7M | $11.8M | $35.3M | $48.5M | $63.9M | $93.8M | -$172.9M | -$152.6M | -$158.7M | -$138.4M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.4M | $13.1M | $15.9M | $21.3M | $5.4M | $16.9M | $16.4M | $20.8M | $25.2M | $29.7M | $34.2M | $42.6M | $46.5M | $50.8M | $59.4M | $43.7M | $48.0M | $24.2M | $27.2M | $31.0M | $4.8M | $5.9M | $10.4M | $22.4M | $29.5M | $7.3M | $7.6M | $15.0M | $15.4M | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$632.5M | -$628.6M | -$627.7M | -$649.2M | -$619.2M | -$610.8M | -$487.6M | -$478.4M | -$473.7M | -$469.5M | -$458.3M | -$452.9M | -$448.8M | -$441.0M | -$437.5M | -$433.3M | -$422.1M | -$415.9M | -$408.5M | -$397.7M | -$393.1M | -$389.5M | -$376.2M | -$370.9M | -$367.4M | -$356.1M | -$349.1M | -$346.6M | -$332.8M | -$331.2M | -$325.8M | -$321.7M | -$315.9M | -$306.9M | -$281.2M | -$266.3M | -$249.6M | -$216.3M | -$195.8M | ||||||||
| Property Plant And Equipment Net | $7.0K | $8.0K | $9.0K | $10.0K | $12.0K | $14.0K | $18.0K | $26.0K | $17.0K | $21.0K | $28.0K | $31.0K | $35.0K | $42.0K | $45.0K | $49.0K | $56.0K | $60.0K | $47.0K | $54.0K | $1.0K | $1.0K | $20.0K | $34.0K | $48.0K | $83.0K | $105.0K | $129.0K | $176.0K | $200.0K | $224.0K | $273.0K | $300.0K | $348.0K | $512.0K | $609.0K | $557.0K | $652.0K | $729.0K | ||||||||
| Prepaid Expense And Other Assets Current | $1.2M | $966.0K | $1.3M | $1.8M | $1.4M | $1.8M | $1.7M | $1.7M | $704.0K | $802.0K | $1.1M | $1.5M | $583.0K | $529.0K | $457.0K | $607.0K | $757.0K | $720.0K | $795.0K | $957.0K | $833.0K | $759.0K | $696.0K | $545.0K | $814.0K | $1.0M | $711.0K | $848.0K | $1.2M | $975.0K | $1.2M | $1.9M | $2.0M | $2.6M | $4.3M | $3.3M | $4.4M | $5.3M | $5.9M | ||||||||
| Other Assets Noncurrent | $240.0K | $244.0K | $198.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $10.0K | $10.0K | $12.0K | $140.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | ||||||||
| Liabilities Current | $7.9M | $7.4M | $10.4M | $11.5M | $8.3M | $9.9M | $9.4M | $9.7M | $8.7M | $9.2M | $7.3M | $6.5M | $5.9M | $7.0M | $7.5M | $7.3M | $9.3M | $8.8M | $6.9M | $8.2M | $8.7M | $8.4M | $8.2M | $10.0M | $10.6M | $9.0M | $9.9M | $9.9M | $9.0M | $9.1M | $7.6M | $8.7M | $9.9M | $10.8M | $13.0M | $11.9M | $11.6M | $14.8M | $13.3M | ||||||||
| Liabilities And Stockholders Equity | $12.4M | $15.6M | $19.1M | $25.0M | $8.9M | $18.7M | $18.2M | $27.0M | $30.5M | $35.1M | $43.8M | $48.1M | $51.4M | $60.0M | $44.4M | $48.8M | $25.2M | $28.2M | $32.1M | $6.0M | $8.6M | $11.3M | $23.1M | $30.2M | $8.6M | $8.8M | $16.1M | $16.6M | $28.1M | $16.2M | $19.6M | $26.0M | $27.7M | $36.7M | $62.3M | $74.6M | $89.7M | $122.7M | $57.9M | ||||||||
| Liabilities | $7.9M | $7.4M | $13.1M | $56.6M | $11.0M | $12.6M | $12.2M | $12.5M | $11.6M | $12.2M | $10.4M | $9.6M | $9.1M | $10.3M | $11.4M | $11.7M | $13.0M | $12.6M | $10.7M | $12.0M | $13.1M | $12.9M | $12.3M | $14.3M | $15.5M | $14.9M | $15.7M | $19.3M | $18.1M | $14.2M | $12.8M | $21.8M | $23.2M | $24.1M | $26.6M | $25.6M | $25.4M | $28.9M | $27.5M | ||||||||
| Common Stock Value | $71.0K | $71.0K | $50.0K | $36.0K | $30.0K | $253.0K | $211.0K | $210.0K | $210.0K | $210.0K | $209.0K | $209.0K | $209.0K | $209.0K | $158.0K | $2.4M | $1.8M | $1.7M | $1.7M | $82.0K | $60.0K | $59.0K | $57.0K | $851.0K | $194.0K | $99.0K | $99.0K | $68.0K | $68.0K | $27.0K | $274.0K | $237.0K | $217.0K | $217.0K | $217.0K | $217.0K | $217.0K | $214.0K | $26.0K | ||||||||
| Assets Current | $9.6M | $15.4M | $18.9M | $25.0M | $8.9M | $18.7M | $18.2M | $27.0M | $30.5M | $35.0M | $43.8M | $48.0M | $51.4M | $59.9M | $44.2M | $48.7M | $25.0M | $28.0M | $31.9M | $5.8M | $8.4M | $11.2M | $23.1M | $30.2M | $8.6M | $8.7M | $16.0M | $16.4M | $27.9M | $16.0M | $19.4M | $25.7M | $27.4M | $36.4M | $61.6M | $73.8M | $89.0M | $121.9M | $57.0M | ||||||||
| Assets | $12.4M | $15.6M | $19.1M | $25.0M | $8.9M | $18.7M | $18.2M | $27.0M | $30.5M | $35.1M | $43.8M | $48.1M | $51.4M | $60.0M | $44.4M | $48.8M | $25.2M | $28.2M | $32.1M | $6.0M | $8.6M | $11.3M | $23.1M | $30.2M | $8.6M | $8.8M | $16.1M | $16.6M | $28.1M | $16.2M | $19.6M | $26.0M | $27.7M | $36.7M | $62.3M | $74.6M | $89.7M | $122.7M | $57.9M | ||||||||
| Additional Paid In Capital Common Stock | $637.0M | $636.8M | $633.6M | $617.5M | $617.2M | $505.0M | $493.4M | $492.8M | $492.4M | $492.2M | $491.5M | $491.2M | $490.9M | $490.4M | $470.3M | $468.1M | $432.5M | $429.8M | $428.2M | $391.6M | $388.5M | $387.9M | $387.1M | $386.0M | $359.5M | $349.1M | $348.7M | $343.0M | $341.9M | $332.4M | $331.5M | $324.9M | $319.4M | $318.5M | $316.3M | $314.6M | $313.3M | $309.9M | $22.8M | ||||||||
| Accounts Payable Current | $5.1M | $4.8M | $7.7M | $8.2M | $5.5M | $6.2M | $6.6M | $6.1M | $5.1M | $4.9M | $3.8M | $3.0M | $3.1M | $4.1M | $4.3M | $4.0M | $5.7M | $5.1M | $4.2M | $4.5M | $4.8M | $4.3M | $4.3M | $5.9M | $7.0M | $5.4M | $5.7M | $5.4M | $4.1M | $2.8M | $3.3M | $3.2M | $4.2M | $3.9M | $5.4M | $5.0M | $3.3M | $4.4M | $4.4M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $6.0K | $9.0K | -$19.0K | -$42.0K | -$33.0K | -$33.0K | -$30.0K | -$30.0K | -$28.0K | -$27.0K | -$61.0K | -$41.0K | -$21.0K | -$6.0K | $2.0K | -$2.0K | -$2.0K | -$17.0K | -$24.0K | -$27.0K | -$14.0K | -$18.0K | -$7.0K | -$5.0K | $11.0K | -$1.0K | -$10.0K | -$26.0K | -$17.0K | -$19.0K | -$16.0K | -$18.0K | -$14.0K | -$43.0K | -$8.0K | -$18.0K | $5.0K | ||||||||||
| Receivables Net Current | $2.0M | $1.3M | $1.7M | $1.8M | $2.1M | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $28.0K | $28.0K | $27.0K | $29.0K | $27.0K | $38.0K | $46.0K | $41.0K | $45.0K | $23.0K | $1.7M | $35.0K | $24.0K | $72.0K | $477.0K | $57.0K | $233.0K | $126.0K | $904.0K | $2.1M | $1.4M | $1.5M | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $7.6M | $15.0M | $15.4M | $21.4M | $25.8M | $12.8M | $16.8M | $19.8M | $22.2M | $25.4M | $33.7M | $42.3M | $55.5M | $54.6M | $76.6M | $51.2M | $67.3M | $108.1M | $2.5M | ||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.4M | -$4.4M | -$4.5M | -$4.3M | $29.0M | $8.3M | -$6.6M | $3.2M | -$6.0M | ||||||||||||||||||||||||||||||||||||||
| Contract With Customer Liability Noncurrent | $2.5M | $2.6M | $2.6M | $2.7M | $2.7M | $2.8M | $2.9M | $3.0M | $3.1M | $3.1M | $3.2M | $3.3M | $3.4M | $3.4M | $3.5M | $3.6M | $3.6M | $3.8M | $3.8M | $3.9M | $3.8M | $3.9M | $4.0M | ||||||||||||||||||||||||
| Contract With Customer Liability Current | $226.0K | $226.0K | $226.0K | $227.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $455.0K | $455.0K | $455.0K | ||||||||||||||||||||||||
| Accrued Liabilities Current | $2.8M | $2.6M | $2.5M | $3.1M | $2.7M | $3.5M | $2.6M | $3.3M | $3.4M | $4.1M | $3.4M | $3.2M | $2.6M | $2.7M | $3.0M | $3.1M | $3.3M | $3.4M | $2.5M | $3.4M | |||||||||||||||||||||||||||
| Accrued Expenses And Other Current Liabilities Current | $3.8M | $3.8M | $4.2M | $3.5M | $3.6M | $3.1M | $3.1M | $3.7M | $4.0M | $4.5M | $5.8M | $3.9M | $5.0M | $5.3M | $6.5M | $7.2M | $6.5M | $7.8M | $7.8M | $5.3M | |||||||||||||||||||||||||||
| Minority Interest | $830.0K | $830.0K | $830.0K | $830.0K | $830.0K | $830.0K | $830.0K | $830.0K | $830.0K | $850.0K | $394.0K | $423.0K | $450.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $34.0M | $55.6M | $19.4M | $26.6M | $35.7M | $6.4M | $17.4M | $7.5M | $1.5M | $80.5M | $77.5M | $9.8M | ||
| Investing Cash Flow * | -$3.6M | -$14.0K | -$15.0K | -$55.0K | $39.8M | -$40.6M | -$279.0K | -$241.0K | ||||||
| Operating Cash Flow * | -$29.8M | -$17.9M | -$16.3M | -$19.5M | -$23.1M | -$20.8M | -$22.7M | -$23.8M | -$15.8M | -$31.2M | -$57.6M | -$61.4M | $1.6M | -$14.2M |
| Share Based Compensation | $1.4M | $1.3M | $1.2M | $576.0K | $369.0K | $1.0M | $1.1M | $1.7M | $3.9M | $3.8M | $5.1M | $8.0M | $13.8M | $6.0K |
| Increase Decrease In Accounts Payable | $646.0K | $1.8M | $1.1M | -$2.1M | $562.0K | $232.0K | -$1.5M | $863.0K | $1.9M | -$606.0K | $317.0K | -$1.8M | -$97.0K | $2.2M |
| Depreciation Depletion And Amortization | $12.0K | $16.0K | $14.0K | $14.0K | $13.0K | $14.0K | $55.0K | $88.0K | $96.0K | $150.0K | $434.0K | $446.0K | $319.0K | $316.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $27.0K | $1.3M | $229.0K | -$530.0K | $72.0K | -$109.0K | -$60.0K | -$768.0K | -$244.0K | -$1.2M | -$1.2M | $2.7M | $1.1M | -$253.0K |
| Increase Decrease In Receivables | $1.7M | -$11.0K | $1.0K | -$9.0K | -$61.0K | $63.0K | -$24.0K | $28.0K | -$1.5M | $1.4M | $31.0K | |||
| Proceeds From Issuance Of Common Stock | $55.0M | $8.5M | $21.8M | $35.1M | $7.5M | |||||||||
| Increase Decrease In Contract With Customer Liability | -$226.0K | -$226.0K | -$226.0K | -$226.0K | -$226.0K | -$227.0K | -$398.0K | -$454.0K | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$19.0K | $10.0K | -$19.0K | -$28.0K | $32.0K | -$6.0K | -$15.0K | $34.0K | ||||||
| Proceeds From Warrant Exercises | $495.0K | $10.3M | $5.7M | $2.2M | $1.9M | |||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$5.2M | -$585.0K | $828.0K | -$1.8M | $1.2M | -$378.0K | ||||||||
| Increase Decrease In Deferred Revenue | -$454.0K | -$455.0K | -$8.5M | -$787.0K | -$4.6M | $8.2M | $7.7M | |||||||
| Proceeds From Stock Options Exercised | $24.0K | $589.0K | $3.0K | $963.0K | $157.0K | $165.0K | $154.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $14.0K | $15.0K | $55.0K | $228.0K | $609.0K | $279.0K | $256.0K | |||||||
| Increase Decrease In Accrued Expenses And Other Liabilities Current | -$378.0K | $838.0K | -$1.0M | $653.0K | -$2.0M | -$43.0K | ||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations | -$9.0K | -$9.0K | -$14.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q4 2015 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $13.0K | $35.6M | $14.8M | $33.0K | $8.7M | $40.0K | $1.6M | $853.0K | $6.0K | ||||||
| Investing Cash Flow * | $9.9M | -$284.0K | |||||||||||||
| Operating Cash Flow * | -$5.4M | -$4.4M | -$4.5M | -$4.3M | -$6.6M | -$6.5M | -$6.6M | -$5.5M | -$6.1M | -$4.6M | -$9.9M | -$16.2M | -$13.9M | ||
| Share Based Compensation | $161.0K | $333.0K | $336.0K | $296.0K | $65.0K | $93.0K | $650.0K | $278.0K | $458.0K | $2.2M | $1.4M | $1.3M | $2.5M | ||
| Increase Decrease In Accounts Payable | -$605.0K | $949.0K | $1.0M | $365.0K | -$845.0K | -$88.0K | $295.0K | $848.0K | $84.0K | -$125.0K | -$170.0K | -$408.0K | -$1.3M | ||
| Depreciation Depletion And Amortization | $1.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $8.0K | $16.0K | $23.0K | $24.0K | $72.0K | $141.0K | $98.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$774.0K | -$76.0K | $241.0K | $251.0K | -$115.0K | $145.0K | -$6.0K | -$740.0K | -$679.0K | -$495.0K | $14.0K | $941.0K | |||
| Increase Decrease In Receivables | -$111.0K | -$12.0K | -$1.0K | $1.0K | -$53.0K | $418.0K | $95.0K | -$136.0K | -$98.0K | ||||||
| Proceeds From Issuance Of Common Stock | $122.0K | $35.1M | $9.1M | $1.6M | $1.8M | ||||||||||
| Increase Decrease In Contract With Customer Liability | -$57.0K | -$56.0K | -$56.0K | -$56.0K | -$56.0K | -$56.0K | -$57.0K | -$114.0K | -$113.0K | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $23.0K | -$7.0K | $6.0K | -$7.0K | -$16.0K | -$6.0K | -$6.0K | $8.0K | $5.0K | ||||||
| Proceeds From Warrant Exercises | $14.0K | $480.0K | $10.0M | $5.7M | $33.0K | $16.0K | |||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$602.0K | -$747.0K | $142.0K | -$532.0K | -$1.9M | -$1.3M | |||||||||
| Increase Decrease In Deferred Revenue | -$113.0K | -$114.0K | -$114.0K | -$447.0K | -$1.1M | ||||||||||
| Proceeds From Stock Options Exercised | $17.0K | $853.0K | $6.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $72.0K | $284.0K | |||||||||||||
| Increase Decrease In Accrued Expenses And Other Liabilities Current | -$1.3M | -$324.0K | -$223.0K | -$361.0K | $162.0K | ||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations | $5.0K | $6.0K | -$30.0K | -$1.0K | $7.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$35.21 | -$22.57 | -$0.91 | -$0.96 | -$2.17 | -$1.49 | -$4.99 | -$40.15 | -$4.44 | -$10.54 | -$2.94 | -$6.12 | -$15.35 | -$14.18 |
| Common Stock Shares Authorized | 125.0M | 250.0M | 125.0M | 125.0M | 250.0M | 250.0M | 250.0M | 25.0M | 25.0M | 75.0M | 75.0M | 75.0M | 30.1M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 174.0M | 14.4M | 4.1M | 600.0K | 4.4M | 2.3M | 21.7M | 10.6M | 2.2M | 2.1M | ||||
| Common Stock Shares Outstanding | 840.3K | 20.9M | 20.9M | 12.4M | 111.2M | 5.7M | 718.1K | 6.8M | 2.5M | 21.7M | 21.5M | 2.6M | ||
| Common Stock Shares Issued | 840.3K | 20.9M | 20.9M | 12.4M | 111.2M | 5.7M | 718.1K | 6.8M | 2.5M | 21.7M | 21.5M | 2.6M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 1.6M | 839.6K | 20.9M | 16.8M | 11.6M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.6M | 839.6K | 20.9M | 16.8M | 11.6M | |||||||||
| Earnings Per Share Basic | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.34 | -$0.11 | $2.09 | -$1.49 | -$20.52 | -$5.92 | -$5.64 | -$0.20 | -$0.28 | -$0.26 | -$0.19 | -$0.20 | -$0.22 | -$0.27 | -$0.32 | -$0.52 | -$0.65 | -$0.03 | -$0.75 | -$0.60 | -$1.29 | -$0.94 | -$1.10 | -$5.04 | -$10.60 | -$0.29 | -$1.23 | -$0.29 | -$1.96 | -$2.65 | -$2.60 | -$4.13 | -$0.57 | -$0.62 | -$0.69 | -$0.77 | -$0.87 | -$0.68 | -$1.34 | -$5.21 | -$6.08 | -$4.89 | -$1.02 | -$3.84 | -$5.53 | ||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 30.1M | ||||||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 16.0M | 15.8M | 219.2M | 12.1M | 11.3M | 160.3M | 6.1M | 5.9M | 5.9M | 5.7M | 4.1M | 1.0M | 656.7K | 9.0M | 6.8M | 5.4M | 2.7M | 2.7M | 2.3M | 2.2M | 21.7M | 21.7M | 21.7M | 21.7M | 21.6M | 21.4M | 15.5M | 2.6M | 2.6M | 2.3M | 2.2M | 2.2M | 2.2M | ||||||||||||||
| Common Stock Shares Outstanding | 7.1M | 7.1M | 5.1M | 3.7M | 3.0M | 25.3M | 21.1M | 21.0M | 21.0M | 21.0M | 20.9M | 20.9M | 20.9M | 20.9M | 15.8M | 236.7M | 184.5M | 11.6M | 167.4M | 8.2M | 6.0M | 5.9M | 5.7M | 85.1M | 19.4M | 9.9M | 9.9M | 6.8M | 6.8M | 2.7M | 27.4M | 23.7M | 21.7M | 21.7M | 21.7M | 21.7M | 21.6M | 21.4M | 2.6M | ||||||||
| Common Stock Shares Issued | 7.1M | 7.1M | 5.1M | 3.7M | 3.0M | 25.3M | 21.1M | 21.0M | 21.0M | 21.0M | 20.9M | 20.9M | 20.9M | 20.9M | 15.8M | 236.7M | 184.5M | 174.2M | 167.4M | 8.2M | 6.0M | 5.9M | 5.7M | 85.1M | 19.4M | 9.9M | 9.9M | 6.8M | 6.8M | 2.7M | 27.4M | 23.7M | 21.7M | 21.7M | 21.7M | 21.7M | 21.6M | 21.4M | 2.6M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||||||
| Preferred Stock Shares Outstanding | 6.7K | 6.7K | 7.4K | 7.4K | 7.4K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 7.4K | 7.4K | 7.4K | 7.4K | 7.4K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 8.8M | 5.8M | 7.0M | 961.5K | 1.0M | 841.7K | 840.1K | 21.0M | 21.0M | 20.9M | 20.9M | 20.9M | 16.0M | 15.8M | 14.6M | ||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 8.8M | 5.8M | 7.2M | 961.5K | 1.0M | 841.7K | 840.1K | 21.0M | 21.0M | 20.9M | 20.9M | 20.9M | 16.0M | 15.8M | 14.6M | ||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.34 | $-0.11 | $2.17 | $-1.49 | $-20.52 | $-5.92 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.19 | $-0.20 | $-0.22 | $-0.27 | $-0.32 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $24.4M | -$321.0K | $208.0K | -$63.0K | -$1.6M | -$1.6M | -$4.0M | -$20.0K | -$42.0K | -$367.0K | -$1.3M | |||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $1.3M | $1.2M | $576.0K | $369.0K | $1.0M | $1.1M | $1.7M | $3.9M | $3.8M | $5.1M | $5.5M | ||
| Stock Issued During Period Value New Issues | $55.0M | $9.1M | $6.4M | $1.0M | $7.5M | $79.8M | ||||||||
| Stock Issued During Period Shares New Issues | 5.0M | 1.3M | 1.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $3.0K | -$146.0K | -$26.5M | -$530.0K | -$427.0K | $636.0K | -$56.0K | $56.0K | $63.0K | -$476.0K | -$32.0K | $427.0K | -$129.0K | -$513.0K | -$812.0K | $210.0K | -$3.5M | $1.5M | -$2.7M | -$8.0K | -$271.0K | -$1.0K | -$3.0K | -$16.0K | -$61.0K | $31.0K | $2.0K | -$14.0K | -$2.0K | $25.0K | -$999.0K | $609.0K | ||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $135.0K | $105.0K | $161.0K | $343.0K | $380.0K | $333.0K | $360.0K | $273.0K | $336.0K | $305.0K | $241.0K | $296.0K | $190.0K | $60.0K | $65.0K | $90.0K | $92.0K | $93.0K | $145.0K | $155.0K | $650.0K | $295.0K | $211.0K | $327.0K | $458.0K | $2.2M | $1.4M | $1.3M | ||||||||||||||||
| Stock Issued During Period Value New Issues | $113.0K | $3.0M | $115.0K | $427.0K | $19.9M | $35.1M | $9.1M | $3.0M | $392.0K | $40.0K | $1.0M | |||||||||||||||||||||||||||||||||
| Stock Issued During Period Shares New Issues | 3.7M | 467.0K | 61.3K | 24.2K | 16.0K | 861.00 |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.